NewAmsterdam Pharma Company N.V. (NAMS)

NAMS Statistics

Total Valuation

NAMS has a market cap or net worth of $3.95 billion. The enterprise value is $3.19 billion.

Market Cap	3.95B
Enterprise Value	3.19B

Important Dates

The next estimated earnings date is Wednesday, February 25, 2026, before market open.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

NAMS has 113.39 million shares outstanding. The number of shares has increased by 25.71% in one year.

Current Share Class	113.39M
Shares Outstanding	113.39M
Shares Change (YoY)	+25.71%
Shares Change (QoQ)	+0.37%
Owned by Insiders (%)	0.99%
Owned by Institutions (%)	62.48%
Float	62.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	111.89
Forward PS	n/a
PB Ratio	5.41
P/TBV Ratio	5.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	90.55
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.57, with a Debt / Equity ratio of 0.00.

Current Ratio	12.57
Quick Ratio	12.41
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -39.94% and return on invested capital (ROIC) is -22.90%.

Return on Equity (ROE)	-39.94%
Return on Assets (ROA)	-20.70%
Return on Invested Capital (ROIC)	-22.90%
Return on Capital Employed (ROCE)	-27.87%
Revenue Per Employee	$457,701
Profits Per Employee	-$2.87M
Employee Count	77
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +46.88% in the last 52 weeks. The beta is 0.07, so NAMS's price volatility has been lower than the market average.

Beta (5Y)	0.07
52-Week Price Change	+46.88%
50-Day Moving Average	36.01
200-Day Moving Average	26.97
Relative Strength Index (RSI)	52.63
Average Volume (20 Days)	716,937

Short Selling Information

Short Interest	6.21M
Short Previous Month	6.26M
Short % of Shares Out	6.53%
Short % of Float	n/a
Short Ratio (days to cover)	6.27

Income Statement

In the last 12 months, NAMS had revenue of $35.24 million and -$221.07 million in losses. Loss per share was -$1.95.

Revenue	35.24M
Gross Profit	35.24M
Operating Income	-202.93M
Pretax Income	-221.07M
Net Income	-221.07M
EBITDA	-202.72M
EBIT	-202.93M
Loss Per Share	-$1.95

Balance Sheet

The company has $702.95 million in cash and $266,000 in debt, with a net cash position of $755.77 million or $6.67 per share.

Cash & Cash Equivalents	702.95M
Total Debt	266,000
Net Cash	755.77M
Net Cash Per Share	$6.67
Equity (Book Value)	728.07M
Book Value Per Share	6.43
Working Capital	674.06M

Cash Flow

In the last 12 months, operating cash flow was -$144.39 million and capital expenditures -$149,000, giving a free cash flow of -$144.54 million.

Operating Cash Flow	-144.39M
Capital Expenditures	-149,000
Free Cash Flow	-144.54M
FCF Per Share	-$1.27

Margins

Gross Margin	100.00%
Operating Margin	-575.81%
Pretax Margin	-627.28%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NAMS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.71%
Shareholder Yield	-25.71%
Earnings Yield	-5.60%
FCF Yield	-3.66%

Analyst Forecast

The average price target for NAMS is $46.56, which is 33.76% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$46.56
Price Target Difference	33.76%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	70.87%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NAMS has an Altman Z-Score of 22.52 and a Piotroski F-Score of 2.

Altman Z-Score	22.52
Piotroski F-Score	2